The semaglutide group, initially losing an average of 17.3% of their body weight, returned to 5.6% below their starting weight
Seek immediate medical attention if cravings occur alongside : Symptoms of hypoglycemia (trembling, sweating, confusion, rapid heartbeat, dizziness) Severe nausea, vomiting, or abdominal pain Severe upper abdominal pain radiating to the back (possible pancreatitisstop medication immediately) Right upper quadrant abdominal pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Discuss at scheduled follow-up appointments : Persistent, intense cravings that interfere with daily functioning Unexplained weight gain or inability to lose weight despite medication adherence Symptoms of depression, anxiety, or disordered eating patterns Questions about medication dosage or administration Healthcare providers can assess whether medication dosage adjustments are appropriate, evaluate for potential hypoglycemia, and screen for underlying conditions that may contribute to cravings, such as insulin resistance or thyroid disorders
CagriSema , a combination of semaglutide and cagrilintide (an amylin receptor agonist), represents another approach
Overuse, dehydration, electrolyte imbalance, and long-term digestive issues are all possible
UCLA Health
